Hims & Hers Health vs PTC Therapeutics
Hims & Hers Health (HIMS), health care, and PTC Therapeutics (PTCT), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
PTC Therapeutics is worth $5B on the stock market and Hims & Hers Health $4.1B: PTC Therapeutics is valued at 23% more. Hims & Hers Health's operating margin in its latest fiscal year was 4.50% and PTC Therapeutics's 50.1%. Over the past year Hims & Hers Health's share price has moved -48.8% and PTC Therapeutics's -20.5%.
Key facts
- Hims & Hers Health market value
- $4.1B
- PTC Therapeutics market value
- $5B
- Hims & Hers Health revenue
- $2.3BFY to 2025-12-31
- PTC Therapeutics revenue
- $1.7BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Hims & Hers Health | PTC Therapeutics |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $4.1Blower | $5Bhigher |
| Revenue | $2.3Bhigher | $1.7Blower |
| Earnings | $128.4Mlower | $682.6Mhigher |
| Employees | 2,442higher | 991lower |
| Total assets | $2.2Blower | $2.9Bhigher |
| Valuation | ||
| P/E | — | — |
| P/S | 1.8lower | 2.9higher |
| P/B | 11.6 | — |
| Dividend yield | 0.00% | 0.00% |
| Profitability | ||
| Operating margin | 4.50%lower | 50.1%higher |
| Balance sheet | ||
| Net assets | $540.9Mhigher | -$205.3Mlower |
| Total liabilities | $1.6Blower | $3.1Bhigher |
| Total debt | — | — |
| Cash on hand | $228.6Mlower | $984.6Mhigher |
| Price change | ||
| Today | -5.44%lower | -1.00%higher |
| 1 year | -48.8%lower | -20.5%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Hims & Hers Health only (0)
None of the tracked investors.
PTC Therapeutics only (1)
- Louis Bacon0.4%
Percentages are each holding's share of that investor's reported portfolio. · Who owns PTCT
More on Hims & Hers Health
Further comparisons
Hims & Hers Health against its closest peers
PTC Therapeutics against its closest peers
Learn
Questions and answers
Which is bigger, Hims & Hers Health or PTC Therapeutics?
By market value, PTC Therapeutics is the larger: $5B against $4.1B for Hims & Hers Health. By revenue in its latest fiscal year, Hims & Hers Health is the larger: $2.3B against $1.7B for PTC Therapeutics.
Which has the higher operating margin?
PTC Therapeutics: 50.1%, against 4.50% for Hims & Hers Health. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which superinvestors own both Hims & Hers Health and PTC Therapeutics?
None of the tracked superinvestors holds both in their latest 13F filing. 0 hold Hims & Hers Health and 1 holds PTC Therapeutics.
Cite this page
Funkfolio, “Hims & Hers Health vs PTC Therapeutics”, data as of 18 November 2026. https://funkfolio.com/compare/hims-vs-ptct
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.